相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small-cell lung cancer
Charles M. Rudin et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Pancancer survival analysis of cancer hallmark genes
Adam Nagy et al.
SCIENTIFIC REPORTS (2021)
First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Qiang Wu et al.
FRONTIERS IN ONCOLOGY (2021)
Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis
Palanisamy Nallasamy et al.
GASTROENTEROLOGY (2021)
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure
T. C. Lam et al.
LUNG CANCER (2021)
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma
Erin F. Simonds et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Classification of Non-Small Cell Lung Cancer's Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade
Alexander Chi et al.
CANCERS (2021)
Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications
Katyana Amilca-Seba et al.
CANCERS (2021)
Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine
Jin Qian et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer
Kohsuke Isomoto et al.
CLINICAL CANCER RESEARCH (2020)
Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer
Anna Gothlin Eremo et al.
SCIENTIFIC REPORTS (2020)
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer
Yulong Fu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
CD44 as a tumor biomarker and therapeutic target
Hanxiao Xu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
Wubin Ding et al.
EPIGENETICS (2019)
Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?
Tri Le et al.
CANCERS (2019)
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties
Jiahui Si et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
HMDD v3.0: a database for experimentally supported human microRNA-disease associations
Zhou Huang et al.
NUCLEIC ACIDS RESEARCH (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer
Shang-Gin Wu et al.
CANCERS (2019)
Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review
Shen Chen et al.
ONCOTARGETS AND THERAPY (2019)
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Ferdinandos Skoulidis et al.
NATURE REVIEWS CANCER (2019)
ProGRP as early predictive marker of non-small-cell lung cancer to small-cell lung cancer transformation after EGFR-TKI treatment
Yasuhiro Kato et al.
RESPIRATORY MEDICINE CASE REPORTS (2019)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
Overview of current systemic management of EGFR-mutant NSCLC
W. -H. Hsu et al.
ANNALS OF ONCOLOGY (2018)
Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis
Zan-Feng Wang et al.
BMC CANCER (2018)
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells
Marzia Del Re et al.
STEM CELLS (2018)
miRWalk: An online resource for prediction of microRNA binding sites
Carsten Sticht et al.
PLOS ONE (2018)
The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
Takayoshi Shirasaki et al.
SCIENTIFIC REPORTS (2018)
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
Qingzhu Jia et al.
NATURE COMMUNICATIONS (2018)
Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma
Yan Zhang et al.
EXPERIMENTAL CELL RESEARCH (2017)
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
June-Koo Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
T. S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
Jill E. Larsen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set
William C. Reinhold et al.
CANCER RESEARCH (2012)
Overcoming Acquired Resistance to Afatinib in HCC827, a Non-small Cell Lung Cancer Cell Line
J. Hsu et al.
EUROPEAN JOURNAL OF CANCER (2012)
Role of the metastasis-promoting protein osteopontin in the tumour microenvironment
Pieter H. Anborgh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors
Justin M. Balko et al.
BMC GENOMICS (2006)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
分享论文
